FILING ANALYSIS · THURSDAY, NOVEMBER 5
DENTSPLY SIRONA Inc. XRAY — 8-K: Results of Operations and Financial Condition
neutral
DENTSPLY SIRONA Inc. reported Q3 2026 net sales of $836 million and adjusted EPS of $0.29, with a record quarterly sales for Wellspect Healthcare, but also a 7.6% decline in net sales compared to Q3 2025. The company updated its FY2026 outlook to approximately $3.5 billion in net sales and adjusted EPS of $1.20 to $1.30.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →